RBC Capital raised the firm’s price target on Universal Health (UHS) to $231 from $206 and keeps a Sector Perform rating on the shares. The company reported a headline beat and its behavioral volumes showed modest improvement, though remain below the management’s internal targets, the analyst tells investors in a research note. RBC adds it is encouraged by the management’s sizing of the potential impact of the enhanced exchange subsidies expiration.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on UHS:
- Universal Health price target raised to $302 from $280 at UBS
- Universal Health price target raised to $233 from $200 at Morgan Stanley
- Universal Health: Balanced Outlook Amid MSPP Gains and Medicaid Challenges
- Universal Health price target raised to $253 from $227 at Guggenheim
- Universal Health Services Reports Strong Q3 2025 Results